Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (191-200 of 822) with videos related to

Pageof 83
Sort By:
Cancer Letters|January 30, 2025
Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell responsePeng Jin, Menglin Bai, Ji Li, et al.
Journal of Cancer|January 4, 2021
GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathwayDianmin Sun, Yuanyuan Zong, Jinling Cheng, et al.
JTO Clinical and Research Reports|June 6, 2022
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical TrialHui Zhu, Wenxiao Jia, Xuquan Jing, et al.
Frontiers in Oncology|September 25, 2023
Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemiaLili Feng, Philip Y Zhang, Wenda Gao, et al.
Scientific Reports|January 23, 2020
MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumabWang Jing, Hui Zhu, Wenjuan Liu, et al.
Future Oncology (London, England)|March 7, 2020
The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapyDuoying Wang, Dong Guo, Aijie Li, et al.
Oncology Letters|January 25, 2019
Effects of respiratory motion on volumetric and positional difference of GTV in lung cancer based on 3DCT and 4DCT scanningShijiang Wang, Dongping Shang, Xue Meng, et al.
Frontiers in Oncology|February 26, 2021
The Predictive Value of Tumor Volume and Its Change on Short-Term Outcome for Esophageal Squamous Cell Carcinoma Treated With Radiotherapy or ChemoradiotherapyShuai Liang, Chengming Li, Zhenhua Gao, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 20, 2019
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastomaXin Wang, Gaochao Guo, Hui Guan, et al.
Annals of Translational Medicine|March 12, 2021
A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapyPeiliang Wang, Maoqi Yang, Xin Wang, et al.
Pageof 83

Showing results (191-200 of 822) with videos related to

Sort By:
Pageof 83
Cancer Letters|January 30, 2025
Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell responsePeng Jin, Menglin Bai, Ji Li, et al.
Journal of Cancer|January 4, 2021
GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathwayDianmin Sun, Yuanyuan Zong, Jinling Cheng, et al.
JTO Clinical and Research Reports|June 6, 2022
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical TrialHui Zhu, Wenxiao Jia, Xuquan Jing, et al.
Frontiers in Oncology|September 25, 2023
Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemiaLili Feng, Philip Y Zhang, Wenda Gao, et al.
Scientific Reports|January 23, 2020
MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumabWang Jing, Hui Zhu, Wenjuan Liu, et al.
Future Oncology (London, England)|March 7, 2020
The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapyDuoying Wang, Dong Guo, Aijie Li, et al.
Oncology Letters|January 25, 2019
Effects of respiratory motion on volumetric and positional difference of GTV in lung cancer based on 3DCT and 4DCT scanningShijiang Wang, Dongping Shang, Xue Meng, et al.
Frontiers in Oncology|February 26, 2021
The Predictive Value of Tumor Volume and Its Change on Short-Term Outcome for Esophageal Squamous Cell Carcinoma Treated With Radiotherapy or ChemoradiotherapyShuai Liang, Chengming Li, Zhenhua Gao, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 20, 2019
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastomaXin Wang, Gaochao Guo, Hui Guan, et al.
Annals of Translational Medicine|March 12, 2021
A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapyPeiliang Wang, Maoqi Yang, Xin Wang, et al.
Pageof 83